SYNH Average Annual Return 10 Years
Growth of $10,000.00
Without Dividends Reinvested Into SYNH

Also see:
SYNH stock yearly return 2014
SYNH stock yearly return 2015
SYNH stock yearly return 2016
SYNH stock yearly return 2017
SYNH stock yearly return 2018
SYNH stock yearly return 2019
SYNH stock yearly return 2020
SYNH YTD return
Compare SYNH average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Start date: 11/10/2014
End date: 12/06/2021
Start price/share: $20.67
End price/share: $98.96
Dividends collected/share: $0.00
Total return: 378.76%
SYNH Average Annual Return: 24.77%
Starting investment: $10,000.00
Ending investment: $47,878.89
Years: 7.08

SYNH average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
Syneos Health is a holding company. Through its subsidiaries, Co. is a biopharmaceutical solutions organization providing a suite of clinical and commercial services to customers in the biopharmaceutical, biotechnology, and medical device industries. Co. has two reportable segments: Clinical Solutions, which provides a variety of clinical development services spanning Phase I to Phase IV, including global studies, unbundled service offerings, and Real World Evidence studies; and Commercial Solutions, which provides customers with a range of commercialization services, including field teams and medication adherence services, communications solutions, and consulting services. The SYNH average annual return since 2014 is shown above.

The Average Annual Return on the SYNH average annual return since 2014 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether SYNH average annual return since 2014 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the SYNH average annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes

Email EnvelopeFree SYNH Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Syneos Health (SYNH) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

SYRS Average Annual Return
TALS Average Annual Return
TARA Average Annual Return
TARO Average Annual Return
TARS Average Annual Return
TCDA Average Annual Return
TCMD Average Annual Return
TCON Average Annual Return
TCRR Average Annual Return
TCRX Average Annual Return
More Healthcare companies »


SYNH Average Annual Return 10 Years | | Copyright © 2021 - 2021, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.